Clinical Research Directory
Browse clinical research sites, groups, and studies.
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
Sponsor: M.D. Anderson Cancer Center
Summary
This study investigates whether molecular testing can help to predict the risk of endometrial cancer coming back (recurrence) after treatment in patients diagnosed with low risk endometrial cancer and scheduled to have surgery to remove the uterus and/or cervix (hysterectomy). Having sentinel lymph node mapping performed may help researchers to see if the cancer has spread in patients with low risk endometrial cancer.
Official title: Prediction of Recurrence Among Low Risk Endometrial Cancer Population
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
518
Start Date
2012-11-08
Completion Date
2026-12-31
Last Updated
2026-03-09
Healthy Volunteers
No
Conditions
Interventions
Bilateral Salpingectomy with Oophorectomy
Undergo standard of care bilateral salpingo-oophorectomy
Biospecimen Collection
Undergo collection of blood and tissue samples
Hysterectomy
Undergo standard of care hysterectomy
Laboratory Biomarker Analysis
Correlative studies
Lymph Node Mapping
Undergo sentinel lymph node mapping
Sentinel Lymph Node Biopsy
Undergo sentinel lymph node biopsy
Locations (1)
M D Anderson Cancer Center
Houston, Texas, United States